SIRT1 and metabolic dysfunction-associated steatotic liver disease: These protective effects may be attributed to, at least partly, the stimulating effects on the AMPK/SIRT1 and Nrf2/HO-1 signaling pathways and suggest the LF potential application in the treatment of NAFLD.